Sp1272
OPTIMIZING MANAGEMENT OF CONSTIPATION AND ABDOMINAL SYMPTOMS IN IBS-C
Date
May 7, 2023
Society: DDW
Constipation and abdominal symptoms are the hallmark symptoms of irritable bowel syndrome with constipation (IBS-C), a chronic and burdensome condition. Come to a clinical review to learn more about management of IBS-C in adult patients. Sponsored by AbbVie
Constipation and abdominal symptoms are the hallmark symptoms of irritable bowel syndrome with constipation (IBS-C), a chronic and burdensome condition. Come to a clinical review to learn more about management of IBS-C in adult patients. Sponsored by AbbVie
Presenter
Tracks
Related Products
RNA SEQUENCING FROM BIOPSIES PERFORMED DURING FOOD ELIMINATION AND REINTRODUCTION IDENTIFIES SIGNATURES INVOLVED IN EARLY RECURRENCE OF EOE
RATIONALE: RNA sequencing studies have previously identified impaired barrier function and the subsequent proinflammatory response as critical to the pathogenies of EoE. However, the investigation into disease initiation is often limited by the inability to capture the disease early…
COMPARATIVE ANALYSIS OF GENE EXPRESSION PROFILES OF ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS BASED ON ANATOMICAL CLASSIFICATION
BACKGROUND: Siewert's topographic classification (SW) has been used for treatment plan of esophagogastric junction adenocarcinomas (EGJA). But recently, molecular classifications categorized EGJA with similar characteristics and prognosis…
SURVODUTIDE REDUCES LIVER FAT CONTENT, TRANSAMINASES, AND FIBROSIS MARKERS WITH GOOD SAFETY PROFILE IN PEOPLE WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): AN INTERIM ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL
BACKGROUND: Survodutide is a novel glucagon receptor/glucagon-like peptide-1 receptor dual agonist under investigation for treatment in advanced liver disease associated with metabolic dysfunction-associated steatohepatitis (MASH), the most severe form of metabolic dysfunction-associated steatotic…
